The relationship between inflammation and cancer represents one of the central paradoxes in modern tumor immunology. On one hand, chronic inflammation is a ...

For 10% of colorectal cancer patients, hereditary factors play a role, with higher percentages among younger patients.

KAIST researchers have developed a way to reprogram immune cells already inside tumors into cancer-killing machines. A drug ...